RESMED, INC.
RMD
 Delayed - 06/24 04:00:02 pm |
|
| 211.5USD | +1.93% |
Business Summary
| Healthcare | ||||
 | Healthcare Services | |||
| Healthcare Equipment & Supplies | |||
| Advanced Medical Equipment & Technology | |||
| Other Advanced Medical Equipment & Technology | |||
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Number of employees : 7 970 people.
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Number of employees : 7 970 people.
Sales per Business
| 2020 | 2021 | ||||
| Sleep and Respiratory Care | 2 602.38 | 88% | 2 823.24 | 88.3% | |
| Software as a Service | 356.73 | 12.1% | 373.59 | 11.7% | |
| USD in Million | |||||
Sales per region
| 2020 | 2021 | ||||
| United States | 1 828.57 | 61.8% | 1 962.72 | 61.4% | |
| Europe, Asia, and Other Markets | 1 030.05 | 34.8% | 1 118.12 | 35% | |
| Canada, Latin America | 98.38 | 3.3% | 115.98 | 3.6% | |
| USD in Million | |||||
Managers
| Name | Title |
| Michael J. Farrell | Director-Business Development |
| Robert Andrew Douglas | Vice President-Corporate Marketing |
| Brett A. Sandercock | Chief Financial Officer |
| Peter C. Farrell | Non-Executive Chairman |
| Carlos M. Nunez | Chief Medical Officer |
| Urvashi Tyagi | Chief Technology Officer |
| David Brian Pendarvis | Secretary & General Counsel |
| Richard Sulpizio | Independent Director |
| Ronald R. Taylor | Director |
| Carol J. Burt | Independent Director |
| Shareholders |
| Name | Equities | % |
| The Vanguard Group, Inc. | 15,280,044 | 10.4% |
| Capital Research & Management Co. | 9,808,000 | 6.70% |
| WCM Investment Management LLC | 8,613,592 | 5.89% |
| Friess Associates LLC | 7,007,200 | 4.79% |
| SSgA Funds Management, Inc. | 6,490,977 | 4.44% |
| Principal Global Investors (Australia) Ltd. | 6,378,620 | 4.36% |
| Fidelity Management & Research Co. LLC | 6,188,198 | 4.23% |
| Capital Research & Management Co. (World Investors) | 4,470,998 | 3.06% |
| BlackRock Fund Advisors | 3,098,697 | 2.12% |
| Geode Capital Management LLC | 2,921,359 | 2.00% |
Company contact information
9001 Boulevard Spectrum Center
CA 92123 San Diego, California
Phone : +1 858-836-5971
Fax :
web site : https://investor.resmed.com/
CA 92123 San Diego, California
Phone : +1 858-836-5971
Fax :
web site : https://investor.resmed.com/
Markets and indexes
| - Main Market |
| - S&P 500 / |
Stock Exchange Codes
Sector Other Advanced Medical Equipment & Technology
| 1st jan. | Capi. (M$) | ||
 | |||
| RESMED INC. | -14.90% | 30 965 | |
| |||
| THERMO FISHER SCIENTIFIC | -18.98% | 213 272 | |
| DANAHER CORPORATION | -22.44% | 183 863 | |
| INTUITIVE SURGICAL, INC. | -41.64% | 75 262 | |
| EDWARDS LIFESCIENCES CORPORATION | -25.14% | 60 297 | |
| SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. | -16.15% | 57 728 | |
| SIEMENS HEALTHINEERS AG | -28.85% | 55 403 | |
| BOSTON SCIENTIFIC CORPORATION | -10.50% | 54 352 | |
| AGILENT TECHNOLOGIES, INC. | -25.71% | 36 230 | |
| RESMED, INC. | -18.80% | 30 965 | |
| ILLUMINA, INC. | -49.02% | 30 466 | |
| OLYMPUS CORPORATION | 1.21% | 25 268 | |
| WATERS CORPORATION | -13.73% | 19 792 | |
| PHILIPS NV | -37.10% | 19 378 | |
| PERKINELMER, INC. | -27.62% | 18 358 | |
| HOLOGIC, INC. | -7.85% | 17 689 | |
| ABIOMED, INC. | -28.91% | 11 633 | |
| CARL ZEISS MEDITEC AG | -38.25% | 10 770 | |
| BRUKER CORPORATION | -23.51% | 9 579 | |
| MICROPORT SCIENTIFIC CORPORATION | -18.49% | 5 357 | |
| GN STORE NORD A/S | -40.63% | 4 424 | |
Brand Portfolio
